Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: the cognitive reserve theory

Neurobiology of Disease
Julien DumurgierJacques Hugon

Abstract

In Alzheimer's disease (AD), the cognitive reserve theory predicts that at any level of assessed clinical severity, the underlying brain pathology is more advanced in patients with more cognitive reserve. Recent evidences suggest that cerebrospinal fluid (CSF) biomarkers may reflect the brain pathology in AD. We investigated the relationship between education level and CSF concentrations of β-amyloid, total tau and phosphorylated tau (ptau-181) in a cohort of 70 subjects newly diagnosed with AD. We report that CSF concentration of β-amyloid was inversely associated with years of education, after adjustment for age, sex, and severity of the disease. We further demonstrate in stratified analysis that this relation was mainly present in mild form of the disease (CDR1), and was attenuated in more advanced forms of the disease. These results are consistent with the cognitive reserve theory, and suggest that cognitive reserve may be protective against amyloid related cognitive impairment at the onset of the clinical dementia.

References

Sep 1, 1975·Archives of Neurology·V C HachinskiL Symon
May 3, 2006·Psychological Medicine·Michael J Valenzuela, Perminder Sachdev
Jun 15, 2006·Alzheimer Disease and Associated Disorders·Yaakov Stern
Oct 3, 2006·Brain : a Journal of Neurology·Katharina BuergerHarald Hampel
Feb 20, 2009·Dementia and Geriatric Cognitive Disorders·S RolstadA Wallin
Apr 4, 2009·Annals of Clinical Biochemistry·N A VerweyM A Blankenstein
May 15, 2009·Brain : a Journal of Neurology·Olivier QuerbesUNKNOWN Alzheimer's Disease Neuroimaging Initiative
May 27, 2009·Neuropsychologia·Yaakov Stern
Aug 18, 2009·Dementia and Geriatric Cognitive Disorders·S RolstadA Wallin
Jan 20, 2010·Lancet Neurology·Clifford R JackJohn Q Trojanowski
Mar 31, 2010·Journal of Psychosocial Nursing and Mental Health Services·David E VancePariya L Fazeli
Apr 8, 2010·Annals of Neurology·Dorene M RentzKeith A Johnson

❮ Previous
Next ❯

Citations

Nov 8, 2011·Journal of Molecular Neuroscience : MN·Hanna Rosenmann
Apr 12, 2011·Brain : a Journal of Neurology·Prashanthi VemuriUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 11, 2013·Alzheimer's Research & Therapy·Benjamin LamSandra E Black
Jan 16, 2013·PloS One·Julien DumurgierUNKNOWN Groupe d’Investigation du Liquide Cephalorachidien (GIL) Study Network
Jul 16, 2014·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Audrey GabelleClaudine Berr
Jul 30, 2015·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Anders WallinMaria Bjerke
Oct 19, 2017·Journal of Alzheimer's Disease : JAD·Julien DumurgierTeresa Gómez-Isla
Jan 16, 2019·Annual Review of Public Health·Bryan D James, David A Bennett
Nov 13, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Julien DumurgierAudrey Gabelle
Jun 21, 2017·Journal of Neurology, Neurosurgery, and Psychiatry·R Ryan DarbyUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jan 11, 2019·Current Neurology and Neuroscience Reports·Corinne Pettigrew, Anja Soldan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.